| Market Cap | ₹3,253Cr |
| ROE | 2.35% |
| P/E Ratio(TTM) | 183.48 |
| EPS(TTM) | 7.58 |
| P/B Ratio | 4.31 |
| Dividend Yield | 0.07% |
| Industry P/E | 41.72 |
| Book Value | 322.50 |
| Debt to Equity | 0.11 |
| Face Value | 10 |
| Parent Organisation | Tatva Chintan Pharma Chem |
| Managing Director | Chintan Nitinkumar Shah |
| Founded | 1996 |
| NSE Symbol | TATVA |
| FUND NAME | AUM(%) |
|---|---|
| Nippon India ELSS Tax Saver Fund Direct Growth | 0.50% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Foseco India | NA (0.00%) | 39.52 | ||
| Fineotex Chemical | NA (0.00%) | 28.28 | ||
| Paushak | NA (0.00%) | 32.14 | ||
| Platinum Industries | NA (0.00%) | 32.18 |